How Much Does Jatenzo Cost in North Carolina in 2026?

Jatenzo Retail Pricing Across North Carolina

The average cash-pay cost for brand-name Jatenzo at North Carolina retail pharmacies is $900 per month in 2026. This price reflects the manufacturer list price set by Tolmar Pharmaceuticals and remains consistent whether you fill at a chain pharmacy in Charlotte, an independent in Raleigh, or a specialty pharmacy in Asheville.

Jatenzo received FDA approval in March 2019 as the first oral testosterone undecanoate capsule for adult males with hypogonadism. The key registration trial by Swerdloff et al. enrolled 166 hypogonadal men and demonstrated that 87% achieved average testosterone concentrations within the normal range (300 to 1 to 100 ng/dL) at the final titrated dose over 105 days of treatment [1]. Unlike older injectable or topical formulations, the oral route eliminates injection-site reactions and transference risk to household contacts. The trade-off is cost. At $10,800 annually before any discount or insurance, Jatenzo sits at a substantially higher price point than generic testosterone cypionate injections, which typically run $30 to $80 per month in North Carolina. This price differential is the primary barrier to access for most NC patients considering oral TRT.

Pharmacy-to-pharmacy variation in cash price is minimal because Jatenzo distribution uses a limited specialty network. Price-comparison tools like GoodRx may show slight differences of $20 to $50 between pharmacies, but the base cost remains close to $900.

North Carolina Medicaid Coverage for Jatenzo

North Carolina Medicaid does not cover Jatenzo for standard male hypogonadism diagnoses. The state formulary restricts oral testosterone undecanoate to narrow indications, and the standard hypogonadism ICD-10 codes (E29.1, E89.5) do not qualify for coverage under current NC Medicaid pharmacy benefits.

This exclusion means that the approximately 2.9 million North Carolinians enrolled in Medicaid or Medicaid Managed Care plans cannot access brand-name Jatenzo through their pharmacy benefit. NC Medicaid does cover generic injectable testosterone cypionate and topical testosterone gel formulations for documented hypogonadism, making those the default TRT options for Medicaid beneficiaries. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone measurements below 300 ng/dL, but does not mandate any specific formulation. Medicaid programs across most states have used this flexibility to limit formulary inclusion to lower-cost preparations.

Patients on NC Medicaid who specifically need oral testosterone undecanoate (for example, those with injection phobia or documented skin reactions to topical gels) may attempt a non-formulary exception request. Success rates for these appeals are low without documented failure of at least two preferred agents. A prescribing physician must submit clinical documentation showing medical necessity beyond patient preference.

Commercial Insurance Coverage in North Carolina

Most commercial insurance plans operating in North Carolina (Blue Cross Blue Shield of NC, Aetna, Cigna, UnitedHealthcare) place Jatenzo on specialty or non-preferred brand tiers, requiring prior authorization and step therapy through generic testosterone first.

Prior authorization criteria typically require: confirmed hypogonadism with two morning total testosterone levels below 300 ng/dL [2], documented trial and failure of (or contraindication to) injectable testosterone cypionate, and documented trial and failure of (or contraindication to) topical testosterone. Some plans add a third step requiring trial of testosterone nasal gel (Natesto) before approving Jatenzo. Once approved, patient cost-sharing on a specialty tier ranges from $75 to $250 per month depending on the specific plan design.

Blue Cross Blue Shield of North Carolina, the state's largest commercial insurer, classifies Jatenzo as a Tier 4 specialty medication. Their 2026 formulary requires step therapy through two lower-cost testosterone formulations. UnitedHealthcare plans sold on the NC ACA marketplace similarly require prior authorization with step therapy. The approval process takes 5 to 14 business days in most cases.

For patients whose prior authorization is denied, the external review process through the NC Department of Insurance provides an independent medical review. North Carolina law (N.C.G.S. § 58-50-61) requires insurers to complete internal appeals within 30 days for non-urgent requests.

The Tolmar Savings Card Program

Tolmar Pharmaceuticals offers a manufacturer copay savings card that reduces out-of-pocket costs for commercially insured patients filling Jatenzo prescriptions in North Carolina. The card covers up to $75 off each monthly fill, bringing net patient cost to as low as $0 for patients whose insurance already covers the majority of the drug price.

Eligibility requirements exclude patients with government insurance (Medicare, Medicaid, Tricare, VA). The card is activated through the Jatenzo savings program website and can be used at any participating North Carolina pharmacy. Annual benefit caps typically limit total savings to $1,800 per year ($150 per month equivalent), though Tolmar has periodically adjusted these caps.

For patients paying full cash price without insurance, the savings card provides limited benefit. The $75 monthly reduction brings cash cost from $900 to $825, still a substantial monthly expense. The card delivers the most value for patients whose insurance approves Jatenzo but assigns high cost-sharing. A patient with a $200 specialty tier copay would pay $125 per month after applying the card.

Patients should confirm card acceptance at their specific pharmacy before filling. Some North Carolina specialty pharmacies process manufacturer cards differently than retail chains, and activation may require a phone call to Tolmar's patient support line.

Compounded Oral Testosterone Undecanoate in North Carolina

Licensed 503A compounding pharmacies in North Carolina can legally prepare oral testosterone undecanoate capsules pursuant to a valid patient-specific prescription. This pathway offers a significantly lower cost alternative to brand-name Jatenzo.

Compounded oral testosterone undecanoate from NC-licensed 503A pharmacies typically costs between $100 and $250 per month, representing savings of 70% to 89% compared to brand-name Jatenzo. North Carolina Board of Pharmacy regulations permit 503A compounding when a prescriber documents medical need for a specific formulation that differs from commercially available products (different dose, different excipients, or allergy to inactive ingredients in the brand product).

The legal framework rests on FDA guidance under Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows patient-specific compounding by state-licensed pharmacies operating under a valid prescription. North Carolina does not have additional state-level restrictions prohibiting the compounding of oral testosterone undecanoate specifically. Several NC compounding pharmacies in the Research Triangle, Charlotte metro, and Triad regions offer this preparation.

Quality considerations matter. Compounded preparations do not undergo the same bioequivalence testing as FDA-approved products. The Swerdloff et al. registration trial demonstrated that Jatenzo's self-emulsifying drug delivery system (SEDDS) technology produces reliable testosterone absorption in the lymphatic system, bypassing first-pass hepatic metabolism [1]. Compounded versions may use different lipid vehicles, potentially affecting absorption kinetics. Patients choosing compounded oral testosterone undecanoate should work with prescribers who monitor serum testosterone levels at 4 to 6 weeks after initiation and adjust dosing based on trough levels.

The FDA has expressed concern about compounded copies of commercially available drugs, but enforcement action against 503A pharmacies filling valid patient-specific prescriptions remains rare when the pharmacy operates within state licensure requirements.

Telehealth Access to Jatenzo in North Carolina

North Carolina permits telehealth prescribing of Jatenzo, allowing patients statewide to obtain prescriptions through virtual consultations with licensed providers. This expands access beyond urban centers where endocrinologists and urologists concentrate.

NC telehealth regulations (21 NCAC 32S .0100) require that the prescribing provider holds an active North Carolina medical license and establishes a valid provider-patient relationship, which can occur entirely via synchronous audio-video visit. No in-person visit is required before initiating testosterone therapy via telehealth in North Carolina, though laboratory confirmation of hypogonadism (two morning total testosterone draws below 300 ng/dL) remains mandatory per standard of care [3].

Telehealth TRT clinics operating in North Carolina typically charge $99 to $199 per month for provider visits and monitoring, separate from medication cost. Some bundle laboratory monitoring into their subscription fees. Patients should verify that their telehealth provider can handle the prior authorization process if they plan to use commercial insurance for the Jatenzo prescription itself.

For patients in rural western NC counties or eastern NC areas with limited endocrinology access, telehealth removes the geographic barrier. The prescription can be sent electronically to any NC pharmacy, including mail-order specialty pharmacies that may offer modest price advantages.

Jatenzo Dosing and Cost Per Dose

Jatenzo prescribing information specifies a starting dose of 237 mg taken orally twice daily with food, with titration based on serum testosterone levels measured 2 to 8 hours after the morning dose at steady state (approximately 7 days after initiation) [4].

The available capsule strengths are 158 mg and 237 mg. Dose titration ranges from 158 mg twice daily (minimum) to 396 mg twice daily (maximum), achieved by combining capsule strengths. At all dose levels, the monthly supply costs approximately $900 at retail because Tolmar prices Jatenzo per monthly pack rather than per milligram.

This flat-pricing structure means that patients requiring the maximum 396 mg twice-daily dose pay the same $900 per month as those maintained on 158 mg twice daily. From a cost-per-milligram perspective, higher doses represent better value, though dose selection should be driven entirely by clinical response and testosterone levels, not economics.

The twice-daily dosing with food requirement is clinically important. The SEDDS lipid formulation requires dietary fat for adequate lymphatic absorption. Patients who take Jatenzo on an empty stomach achieve approximately 50% lower testosterone exposure, potentially leading to subtherapeutic levels and unnecessary dose escalation that still fails to resolve symptoms.

Comparing Jatenzo to Other TRT Options in North Carolina

The cost differential between Jatenzo and alternative testosterone formulations available in North Carolina is substantial. Generic testosterone cypionate 200 mg/mL (10 mL vial) costs $30 to $80 per month at NC pharmacies. Topical testosterone gel 1.62% (pump) runs $50 to $150 per month for generic versions. Testosterone nasal gel (Natesto) costs approximately $500 to $600 per month.

Jatenzo's clinical advantage is convenience and safety profile. The Swerdloff trial showed no clinically significant increases in systolic blood pressure at the label-recommended doses, with mean increases of 3 to 5 mmHg observed only at supratherapeutic exposures [1]. The oral route eliminates injection-associated pain, hematoma, and the need for clinic visits or self-injection training. It also eliminates the transference risk that carries an FDA boxed warning on all topical testosterone products.

For NC patients, the decision often comes down to whether the convenience justifies a 10x to 30x cost premium over generic injectables. Patients with needle phobia, those living with children or female partners (transference concern), or those whose occupations make daily topical application impractical may find Jatenzo's cost justified. The Endocrine Society guideline does not preferentially recommend any formulation, stating that "the choice of testosterone formulation should be a joint decision between the patient and provider" based on individual factors including cost, pharmacokinetics, and patient preference [3].

Strategies to Reduce Jatenzo Cost in North Carolina

Several approaches can lower out-of-pocket Jatenzo costs for NC patients beyond the Tolmar savings card.

Patient assistance programs through Tolmar may cover the full cost for uninsured patients meeting income qualifications (typically below 300% of the federal poverty level). Application requires documentation of income and insurance status. Processing takes 4 to 6 weeks.

Specialty pharmacy mail-order options occasionally offer prices $50 to $100 below local retail. Patients should compare pricing at Accredo, AllianceRx Walgreens, and CVS Specialty, all of which ship to North Carolina addresses.

Employer benefit appeals represent an underused pathway. Patients whose employer-sponsored plans deny Jatenzo can request that their HR benefits team petition the plan administrator for formulary exception. Large self-insured employers in NC (banking sector in Charlotte, tech companies in RTP) sometimes have more flexible formulary override processes than fully insured small-group plans.

For patients prioritizing cost, switching to compounded oral testosterone undecanoate through a licensed NC 503A pharmacy remains the most impactful cost-reduction strategy, dropping monthly expense from $900 to the $100 to $250 range while maintaining the oral delivery route.